Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024

20-12-2023 | Pathology | Original Article

Role of CD34-immunopositive Microvascular Density in Juvenile Nasopharyngeal Angiofibroma

Authors: Avinash Shekhar Jaiswal, Rakesh Kumar, Aanchal Kakkar, Rajeev Kumar, Hitesh Verma, Ashu Seith Bhalla, Arvind Kumar Kairo, Alok Thakar

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 2/2024

Login to get access

Abstract

Objective

To assess the microvascular density (MVD) in juvenile nasopharyngeal angiofibroma (JNA) with CD34 immunostaining and evaluate its relationship with clinico-demographic features.

Methods

This prospective study included patients with JNA undergoing endoscopic excision. The histopathological specimen was stained using CD-34 antibodies to calculate MVD. MVD and clinico-demographic features were correlated.

Results

The study included 12 patients with a median age of 15.5 years. The mean MVD was 39 vessels/high power field (range 5 to 151 vessels). MVD was significantly associated only with the volume of tumour (r = 0.65, p = 0.02). The recurrence occurred in one patient with an MVD of 107. The median follow-up was 38 months.

Conclusion

MVD is significantly associated with tumour volume in JNA, which implies a robust role of angiogenesis in the pathology of the tumour. Also, higher MVD may be a risk factor for recurrence.
Literature
1.
go back to reference Jaiswal AS, Kumar R, Thakar A et al (2020) Plasma ablation-assisted endoscopic excision versus traditional technique of endoscopic excision of juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 139:110410CrossRefPubMed Jaiswal AS, Kumar R, Thakar A et al (2020) Plasma ablation-assisted endoscopic excision versus traditional technique of endoscopic excision of juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 139:110410CrossRefPubMed
2.
go back to reference Wang JJ, Sun XC, Hu L et al (2013) Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance. Head Neck 35:1719–1725CrossRefPubMed Wang JJ, Sun XC, Hu L et al (2013) Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance. Head Neck 35:1719–1725CrossRefPubMed
3.
go back to reference Beham A, Regauer S, Beham-Schmid C, Kainz J, Stammberger H (1998) Expression of CD34-antigen in nasopharyngeal angiofibromas. Int J Pediatr Otorhinolaryngol 44:245–250CrossRefPubMed Beham A, Regauer S, Beham-Schmid C, Kainz J, Stammberger H (1998) Expression of CD34-antigen in nasopharyngeal angiofibromas. Int J Pediatr Otorhinolaryngol 44:245–250CrossRefPubMed
4.
go back to reference Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT (1996) Angiofibroma. Changes in staging and treatment. Arch Otolaryngol Head Neck Surg 122:122–129CrossRefPubMed Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT (1996) Angiofibroma. Changes in staging and treatment. Arch Otolaryngol Head Neck Surg 122:122–129CrossRefPubMed
5.
go back to reference Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and Metastasis–correlation in invasive breast carcinoma. N Engl J Med 324(1):1–8CrossRefPubMed Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and Metastasis–correlation in invasive breast carcinoma. N Engl J Med 324(1):1–8CrossRefPubMed
6.
go back to reference Thakar A, Gupta G, Bhalla AS et al (2011) Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head Neck 33:1747–1753CrossRefPubMed Thakar A, Gupta G, Bhalla AS et al (2011) Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head Neck 33:1747–1753CrossRefPubMed
7.
go back to reference Schick B, Urbschat S (2004) New aspects of pathogenesis of juvenile angiofibroma. Hosp Med 65:269–273CrossRefPubMed Schick B, Urbschat S (2004) New aspects of pathogenesis of juvenile angiofibroma. Hosp Med 65:269–273CrossRefPubMed
8.
go back to reference Beham A, Beham-Schmid C, Regauer S, Auböck L, Stammberger H (2000) Nasopharyngeal angiofibroma: true Neoplasm or vascular malformation? Adv Anat Pathol 7:36–46CrossRefPubMed Beham A, Beham-Schmid C, Regauer S, Auböck L, Stammberger H (2000) Nasopharyngeal angiofibroma: true Neoplasm or vascular malformation? Adv Anat Pathol 7:36–46CrossRefPubMed
9.
go back to reference Schick B, Wemmert S, Willnecker V et al (2011) Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma. Int J Oncol 39:1143–1151PubMed Schick B, Wemmert S, Willnecker V et al (2011) Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma. Int J Oncol 39:1143–1151PubMed
10.
go back to reference Saylam G, Yücel OT, Sungur A, Onerci M (2006) Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 70:227–234CrossRefPubMed Saylam G, Yücel OT, Sungur A, Onerci M (2006) Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 70:227–234CrossRefPubMed
11.
go back to reference Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ (2007) Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 264:389–394CrossRefPubMed Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ (2007) Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 264:389–394CrossRefPubMed
13.
go back to reference Zhang M, Sun X, Yu H, Hu L, Wang D (2011) Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study. Acta Histochem 113:626–630CrossRefPubMed Zhang M, Sun X, Yu H, Hu L, Wang D (2011) Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study. Acta Histochem 113:626–630CrossRefPubMed
14.
go back to reference Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ (2004) Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 130:727–731CrossRefPubMed Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ (2004) Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 130:727–731CrossRefPubMed
Metadata
Title
Role of CD34-immunopositive Microvascular Density in Juvenile Nasopharyngeal Angiofibroma
Authors
Avinash Shekhar Jaiswal
Rakesh Kumar
Aanchal Kakkar
Rajeev Kumar
Hitesh Verma
Ashu Seith Bhalla
Arvind Kumar Kairo
Alok Thakar
Publication date
20-12-2023
Publisher
Springer India
Keyword
Pathology
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 2/2024
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-04331-x

Other articles of this Issue 2/2024

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024 Go to the issue